4.8 Article

MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

FoxM1 promotes Wnt/β-catenin pathway activation and renal fibrosis via transcriptionally regulating multi-Wnts expressions

Hongyan Xie et al.

Summary: The study demonstrates that transcriptional factor FoxM1 plays a critical role in renal fibrosis by regulating the expression of multiple Wnt family members. Inhibition of FoxM1 can attenuate renal fibrosis, making it a potential therapeutic target. FoxM1 might act as a key switch in activating the β-catenin pathway and promoting renal fibrosis.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

MYB oncoproteins: emerging players and potential therapeutic targets in human cancer

Ylenia Ciciro et al.

Summary: MYB transcription factors are highly conserved from plants to vertebrates, and their aberrant activation in humans may lead to cancer. Recent detection of MYB gene rearrangements and mutations in human cancer provides smoking gun evidence of the involvement of MYB family members in human malignancies. Studies linking the activity of MYB family members to human cancers and experimental therapeutic interventions tailored for MYB-expressing cancers are highlighted in this review.

ONCOGENESIS (2021)

Article Oncology

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma

Dexin Shen et al.

Summary: CDCA3 is significantly up-regulated in bladder urothelial carcinoma samples and is associated with key clinical characteristics such as tumor grade and metastasis. Higher expression of CDCA3 is correlated with shorter survival. Silencing CDCA3 impairs tumor cell migration and growth by regulating EMT-related proteins and cell cycle progression.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in Esophageal Cancer Patients

Jose Giron Ramirez et al.

Summary: The antagonist protein DKK1 in the canonical Wnt pathway has been linked to various gastrointestinal cancers, particularly in esophageal cancer, where high serum levels of DKK1 appear to have a negative impact on overall survival. This suggests that serum DKK1 could serve as a potential biomarker for risk stratification and treatment monitoring in esophageal cancer patients.

CANCERS (2021)

Article Cell Biology

A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer

Qian Liu et al.

Summary: The study revealed a significant correlation between the expression of MYBL2 and RRM2 in colorectal cancer (CRC), with MYBL2 playing a crucial role in CRC cell proliferation, DNA synthesis, and cell cycle progression in an RRM2-dependent manner. MYBL2 was found to directly bind to the promoter of RRM2 gene and promote its transcription during S-phase in collaboration with TAF15 and MuvB components. Combined suppression of MYBL2 and WEE1 was shown to synergistically inhibit CRC growth with low systemic toxicity in vivo, suggesting a potential novel approach for CRC treatment targeting both transcription and degradation machinery of RRM2.

CELL DEATH & DISEASE (2021)

Article Oncology

CENPA is one of the potential key genes associated with the proliferation and prognosis of ovarian cancer based on integrated bioinformatics analysis and regulated by MYBL2

Jing Han et al.

Summary: This study identified key genes associated with the proliferation and prognosis of ovarian cancer, including CENPA and MYBL2. The MYBL2-CENPA pathway plays an important role in the proliferation of ovarian cancer cells, suggesting it may be a potential target for treatment.

TRANSLATIONAL CANCER RESEARCH (2021)

Article Medicine, Research & Experimental

MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer

Qiji Li et al.

Summary: The research found that MYBL2 is significantly upregulated in CRPC tissues and cells, promoting growth and metastatic capacity. Targeting MYBL2 or using specific inhibitors can reverse resistance to ADT, block bone metastasis, and high MYBL2 levels are associated with increased risk of metastatic relapse and poor prognosis.

THERANOSTICS (2021)

Article Multidisciplinary Sciences

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML

Yue Sheng et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential

Rachel Bayley et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Review Medicine, Research & Experimental

WNT/β-catenin signaling in the development of liver cancers

Shuai He et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Biochemistry & Molecular Biology

The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb

Audra N. Iness et al.

ONCOGENE (2019)

Article Multidisciplinary Sciences

Structural mechanism of Myb-MuvB assembly

Keelan Z. Guiley et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Biology

Cell Synchronization by Double Thymidine Block

Guo Chen et al.

BIO-PROTOCOL (2018)

Review Biochemistry & Molecular Biology

Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

Kurt Engeland

CELL DEATH AND DIFFERENTIATION (2018)

Article Oncology

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma

Xue Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Biochemistry & Molecular Biology

Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α

Fumihiko Okumura et al.

MOLECULAR AND CELLULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

Martin Fischer et al.

NUCLEIC ACIDS RESEARCH (2016)

Review Oncology

FoxM1 and Wnt/β-Catenin Signaling in Glioma Stem Cells

Aihua Gong et al.

CANCER RESEARCH (2012)

Article Cell Biology

The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression

Subhashini Sadasivam et al.

GENES & DEVELOPMENT (2012)

Article Medicine, Research & Experimental

Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma

Yi-Jun Xue et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Review Oncology

Forkhead box M1 transcription factor: A novel target for cancer therapy

Zhiwei Wang et al.

CANCER TREATMENT REVIEWS (2010)

Review Oncology

Role of Wnt canonical pathway in hematological malignancies

G. E. Xueling et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)

Article Biochemistry & Molecular Biology

Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC

NG Ayad et al.